|
|
||||||||
1 Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA
2 Department of Biology, University of Texas at San Antonio, San Antonio, TX, USA
Correspondence
Krishna K. Murthy
kmurthy{at}sfbr.org
Chimpanzees are susceptible to human immunodeficiency virus type-1 (HIV-1) and develop persistent infection but generally do not progress to full-blown AIDS. Several host and immunological factors have been implicated in mediating resistance to disease progression. Chimpanzees have a higher prevalence of circulating natural killer (NK) cells than humans; however, their role in mediating resistance to disease progression is not well understood. Furthermore, NK cell survival and activity have been shown to be dependent on interleukin-15 (IL-15). Accordingly, the influence of IL-15 on NK cell activity and gamma interferon (IFN-
) production was evaluated in naive and HIV-1-infected chimpanzees. In vitro stimulation of whole-blood cultures with recombinant gp120 (rgp120) resulted in enhanced IFN-
production predominantly by the CD3 CD8+ subset of NK cells, and addition of anti-IL-15 to the system decreased IFN-
production. Moreover, in vitro stimulation with recombinant IL-15 (rIL-15) augmented IFN-
production from this subset of NK cells and increased NK cell cytotoxic activity. Stimulation with rgp120 also resulted in a 2- to 7-fold increase in IL-15 production. These findings suggest that chimpanzee CD3 CD8+ NK cells play a vital role in controlling HIV-1 infection by producing high levels of IFN-
, and that IL-15 elicits IFN-
production in this subpopulation of NK cells in HIV-1-infected chimpanzees.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |